• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS COAGUCHEK ® XS SYSTEM; PROTHROMBIN TIME TEST STRIPS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS COAGUCHEK ® XS SYSTEM; PROTHROMBIN TIME TEST STRIPS Back to Search Results
Catalog Number 04625374160
Device Problem Non Reproducible Results (4029)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 11/20/2023
Event Type  malfunction  
Manufacturer Narrative
The coaguchek xs meter's serial number is (b)(6).The doctor's meter serial number was not provided, and the meter type is unknown.The initial reporter stated the doctor's meter looked exactly like the patient's coaguchek xs meter.The product was requested for investigation.The product has not been received at this time.If the product is returned in the future, a follow-up report will be submitted.On a regular basis, coaguchek strips of lots currently valid in the market are tested as part of routine retention testing and results have passed the internal inspection.
 
Event Description
There was an allegation of questionable results from a patient's coaguchek xs meter compared to the doctor's meter.The result on the coaguchek xs meter was 1.9 inr.The result on the doctor's meter was 2.4 inr.The date of the event is unknown.The results were received within a few hours of each other.The patient's therapeutic range is 2.0-2.5 inr.
 
Manufacturer Narrative
The returned meter was tested with retention strips and with retention roche qc level 1 and level 2 controls.Level 1 testing results (qc range = 1.0 - 1.4 inr): qc 1: 1.3 inr.Level 2 testing results (qc range = 2.4 - 3.6 inr): qc 2: 2.9 inr.The obtained results were in the allowed range.No error messages occurred during the investigation.The customer's alleged result of 2.1 inr on (b)(6) 2023 was not observed in the meter's patient result memory.Instead, a result of 2.1 inr was observed on (b)(6) 2023.The customer's alleged result of 2.1 inr on (b)(6) 2023 was not observed in the meter's patient result memory.Instead, a result of 2.5 inr was observed on (b)(6) 2023.The customer's alleged result of 2.0 inr in (b)(6) 2023 was not observed in the meter's patient result memory.A review of the meter's patient result memory observed that the most recent occurrence of the alleged result of 1.9 inr was on (b)(6) 2023.The investigation did not identify a product problem.The cause of the event could not be determined.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
COAGUCHEK ® XS SYSTEM
Type of Device
PROTHROMBIN TIME TEST STRIPS
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
Manufacturer (Section G)
ROCHE DIAGNOSTICS GMBH
sandhofer strasse 116
mannheim (baden-wurttemberg) 68305
GM   68305
Manufacturer Contact
amy nelson
9115 hague road
indianapolis, IN 46250
MDR Report Key18328159
MDR Text Key330576279
Report Number1823260-2023-04006
Device Sequence Number1
Product Code GJS
UDI-Device Identifier00365702127104
UDI-Public00365702127104
Combination Product (y/n)Y
Reporter Country CodeUS
PMA/PMN Number
K062925
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Consumer
Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup
Report Date 12/22/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Catalogue Number04625374160
Device Lot NumberASKU
Was Device Available for Evaluation? Device Returned to Manufacturer
Initial Date Manufacturer Received 11/20/2023
Initial Date FDA Received12/14/2023
Supplement Dates Manufacturer Received12/18/2023
Supplement Dates FDA Received12/22/2023
Was Device Evaluated by Manufacturer? Yes
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
ATORVASTATIN.; CALCIUM.; CARVEDILOL.; FEUROSIMIDE.; JARDIANCE.; POTASSIUM.; PREDNISONE.; STATIN.; TRULICITY.; VITAMIN B12.; VITAMIN D.; WARFARIN.; ZYRTEC.
Patient Age91 YR
Patient SexFemale
Patient Weight62 KG
-
-